OrbiMed Israel GP II, L.P. Insider Trading -- Recent SEC Form 4 Transactions
OrbiMed Israel GP II, L.P. (CIK 1682090) reported 17 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-09-30). Recent activity: Buy ADRX (10.7M shares), Buy ADRX (2.0M shares), Buy ADRX (769,601 shares), Buy ADRX (564,187 shares), Buy ADRX (300,249 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-30 | ADARx Pharmaceuticals, Inc. (ADRX) | Director | Buy | 10.7M | $0 |
| 2026-09-30 | ADARx Pharmaceuticals, Inc. (ADRX) | Director | Buy | 2.0M | $0 |
| 2026-09-30 | ADARx Pharmaceuticals, Inc. (ADRX) | Director | Buy | 769,601 | $0 |
| 2026-09-30 | ADARx Pharmaceuticals, Inc. (ADRX) | Director | Buy | 564,187 | $0 |
| 2026-09-30 | ADARx Pharmaceuticals, Inc. (ADRX) | Director | Buy | 300,249 | $5.1M |
| 2026-09-30 | ADARx Pharmaceuticals, Inc. (ADRX) | Director | Buy | 7.1M | $0 |
| 2026-09-30 | ADARx Pharmaceuticals, Inc. (ADRX) | Director | Buy | 1.3M | $0 |
| 2026-09-30 | ADARx Pharmaceuticals, Inc. (ADRX) | Director | Buy | 513,067 | $0 |
| 2026-09-30 | ADARx Pharmaceuticals, Inc. (ADRX) | Director | Buy | 256,448 | $0 |
| 2026-09-30 | ADARx Pharmaceuticals, Inc. (ADRX) | Director | Buy | 61,516 | $1.0M |
| 2026-09-30 | ADARx Pharmaceuticals, Inc. (ADRX) | Director | Buy | 588,235 | $10.0M |
| 2026-04-09 | Adicet Bio, Inc. (ACET) | 10% Owner | Sell | 29,319 | $191,453 |
| 2026-04-09 | Adicet Bio, Inc. (ACET) | 10% Owner | Sell | 2,400 | $15,312 |
| 2026-04-09 | Adicet Bio, Inc. (ACET) | 10% Owner | Sell | 32,523 | $204,570 |
| 2026-04-09 | Adicet Bio, Inc. (ACET) | 10% Owner | Sell | 40,416 | $263,512 |
| 2025-10-10 | Adicet Bio, Inc. (ACET) | 10% Owner | Buy | 1.5M | $1.5M |
| 2025-10-10 | Adicet Bio, Inc. (ACET) | 10% Owner | Buy | 3.5M | $3.5M |
Source: SEC Form 4 filings · as of 2026-09-30